Inceptionr LLC Invests in Johnson & Johnson $JNJ

Hedge fund acquires new stake in pharmaceutical giant

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Inceptionr LLC, a hedge fund, has acquired a new position in shares of Johnson & Johnson (NYSE:JNJ) in the third quarter, according to a recent SEC filing. The fund purchased 6,004 shares of the company's stock, valued at approximately $1,113,000.

Why it matters

Johnson & Johnson is a major pharmaceutical and consumer healthcare company, and changes in its shareholder base can signal shifts in investor sentiment or strategic priorities. Inceptionr LLC's new investment in JNJ is noteworthy as it suggests the hedge fund sees growth potential in the company's business.

The details

According to the 13F filing, Inceptionr LLC acquired the 6,004 shares of Johnson & Johnson stock in the third quarter of the year. This new position represents a small but meaningful stake in the company, valued at over $1 million. The filing indicates that other hedge funds have also been active in trading JNJ shares recently, with firms like AustralianSuper Pty Ltd and J.W. Cole Advisors Inc. also modifying their holdings.

  • Inceptionr LLC acquired the new position in Johnson & Johnson shares in the third quarter of 2026.

The players

Inceptionr LLC

A hedge fund that has acquired a new position in shares of Johnson & Johnson.

Johnson & Johnson

A multinational pharmaceutical and consumer healthcare company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

Inceptionr LLC's new investment in Johnson & Johnson suggests the hedge fund sees growth potential in the pharmaceutical giant's business, though the size of the stake remains relatively small compared to the company's overall market capitalization.